Major drug companies continually research and develop new medications and treatments for bladder cancer that must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new drugs on a group of volunteers with bladder cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat bladder cancer, its safety, and any possible side effects.
Some patients are reluctant to take part in clinical trials for fear of getting no treatment at all. This is simply not true. Patients who participate in clinical trials receive the most effective therapy currently available for the condition -- or they may receive treatments that are being evaluated for future use. These bladder cancer drugs may be even more effective than current treatment -- comparing them in a clinical trial is the only way to find out.
The bladder is a pouch in the urinary tract that stores urine after it is produced by the kidneys. The bladder is lined with specialized cells called transitional cells.
Bladder cancer often arises from these transitional cells. The cancer spreads by penetrating bladder muscle, infiltrating surrounding fat and tissue, and -- if untreated -- spreads to lymph nodes and other organs, such as the liver, lungs, or bones.
The earlier the cancer is diagnosed, the more limited it will likely be and...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.